scispace - formally typeset
Journal ArticleDOI

Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy

Reads0
Chats0
TLDR
carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections, indicating the importance of their concurrent evaluation, especially during chronic studies.
Abstract
The competitive relationship between d-amphetamine induced stereotypy and locomotor activity indicates the importance of their concurrent evaluation, especially during chronic studies. Repeated injection of 0.5, 1.0, 2.5, 5.0, or 7.5 mg/kg d-amphetamine for 36 successive days, in rats continuously exposed to the experimental chambers, produced a progressive augmentation in stereotypy and/or locomotion (depending on dose) during the 3–4 hr interval following injections (post-injection phase). In contrast, dark phase locomotor activity (8–20 hr after each daily injection) was maximally reduced (30–40% of controls) after the first injection of either 5.0 or 7.5 mg/kg d-amphetamine and gradually declined to this level with repeated injection of 1.0 and 2.5 mg/kg. Carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections. Possible mechanisms underlying these behavioral alterations are discussed.

read more

Citations
More filters
Dissertation

The role of dopamine D2 and neuregulin-1 receptors in schizophrenia relevant phenotypes of cognition, attention and memory

TL;DR: The effects of deletion of two genes relevant to schizophrenia on cognitive tasks known to be disrupted in the disorder are investigated and some evidence is found that reduced function of TM-domain of the Nrg-1 gene disrupted episodic-like memory in males and improved it in females.
Book ChapterDOI

Dopamine receptors hypersensitivity: further confirmation following drug abuse model.

TL;DR: This experiment intended to demonstrate receptor hypersensitivity with less chronic administration of drugs (in this case only six dosages) given in about two weeks, intermittently, and in increasing dosages to stimulate somewhat closer a drug abuse model.
Journal ArticleDOI

Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.

TL;DR: Ceruletide may result in only slight modification of methamphetamine sensitization in the simultaneous administration and post-treatment schedules, although both drugs can antagonize the acute stimulant effect of methamphetamine.
Journal ArticleDOI

Haloperidol prevents the methamphetamine-induced apomorphine subsensitivity of dopamine metabolism in rat striatum

TL;DR: It is demonstrated that haloperidol administered with methamphetamine prevented the effect of the methamphetamine pretreatment, and it is possible that the observed effect of apomorphine upon striatal dopaminergic metabolism and its antagonism with haloperIDol may be mediated by autoreceptors of dopaminaergic axon terminals in rat striatum.
References
More filters
Journal Article

Antiamphetamine effects following inhibition of tyrosine hydroxylase

TL;DR: The antiamphetamine effects of α-MT and other tyrosine hydroxylase inhibitors suggest that a critical level of norepinephrine at the receptor is required for amphetamine to exert its customary effects.
Journal ArticleDOI

Role of Catecholamines in the Amphetamine Excitatory Response

A. Randrup, +1 more
- 30 Jul 1966 - 
TL;DR: The advent of α-methyl para-tyrosine3 (α-MPT), which inhibits the in vivo synthesis of 3,4-dihydroxyphenylalanine (DOPA)—the physiological precursor of the catecholamines—offers a new way of investigating this problem.
Related Papers (5)